Music Therapy for Major Depressive Disorder Residual Symptoms
MTMDDRS
1 other identifier
interventional
48
1 country
1
Brief Summary
Residual Symptoms of Depression (SRD) are those symptoms that persist despite remission of MDD. They are characterized by a high incidence (approx. 90% of patients in remission) at the psychiatric clinic, have become a growing problem. Its presence is associated with a high probability of relapse / recurrence and disability, as determined by decreased performance and low quality of life. Their neglect has generated an increase in clinical and socioeconomic costs, alerting the need for research to provide treatment strategies. The application of different types of psychotherapy has been successful in abating SRD. The present study aims to evaluate the clinical changes related to the application of music therapy as a treatment of SRD, through a randomized controlled trial with two treatment arms trial. Music Therapy (MT) is a psychotherapy provided by specialized health professionals, and is defined as the clinical use of musical evidence-based interventions within a therapeutic relationship. MT treatment group will design an application schema of 8 sessions (2 hrs. Each) over a period of two months (one session per week). The control group will receive the Usual Treatment (TU) which corresponds to the usual clinical psychiatric treatment by the physician in the INPRF, with the same duration. The evaluation will be conducted with clinimetric testing at baseline, at the end of the track and after three months of treatment. This study seeks to identify the presence of SRD in a Mexican sample and explore a treatment designed for that purpose, also, show that the MT is a cost-effective implementation can become a new clinical option to extend the possibilities of assistance and deepen the investigation of this problem.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable major-depressive-disorder
Started Oct 2016
Shorter than P25 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2015
CompletedStudy Start
First participant enrolled
October 1, 2016
CompletedFirst Posted
Study publicly available on registry
October 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedOctober 5, 2016
October 1, 2016
2 months
April 16, 2015
October 4, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hamilton Depression Rating Scale
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
Clinical Interview for Depression and Related Syndromes
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
Secondary Outcomes (5)
Symptom Checklist 90 Revised (SCL-90-R)
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
Beck Depression Inventory
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
WHO Quality of Life-BREF (WHOQOL-BREF)
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
Personal and social performance scale (PSP)
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
Perceived stress scale (PSS)
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
Other Outcomes (1)
Global of Functioning Assessment Scale (GAF)
3 times: Baseline, Change from Baseline at the end of 2 Months Music Therapy and change from baseline at 3 months follow up
Study Arms (2)
Music Therapy
EXPERIMENTALMusic therapy 8 weekly sessions
Usual Treatment
ACTIVE COMPARATORIt is the usual medical treatment.
Interventions
Music therapy (MT) treatment focuses on the use of 2 techniques of intervention: receptive MT and active MT. The work of receptive application is described as the use of prerecorded music or executed by the music therapist with effect on the patient, without the latter's active involvement in the psychotherapeutic process of musical creation. While the active application, both the music therapist and patient are involved in musical creation, for example, the use of voice, body and musical instruments (Muñoz, 2008). Contemplate their psychotherapeutic possibilities in 3 different dimensions of patient: body, emotional and social work, as explained above. Treatment with MT, as in cognitive behavioral therapy, includes breathing exercises, stress-relaxation techniques, psychoeducation, and exercises for the management of irrational thoughts and erratic behavior patterns (Dobson and Dozois, 2010).
It is the usual medical treatment that patients with major depressive disorder in remission but with residual symptom receives at the sponsor institution in a monthly basis.
Eligibility Criteria
You may qualify if:
- Subsequent and file number at the National Institute of Psychiatry "Ramon de la Fuente" patients.
- Male or Female Patients.
- Age 20-45 years.
- Previous diagnosis of MDD according to DSM-IV.
- Presence of residual symptoms, with a score of ≤7 points in the HAM-D-21 and / or ≤9 points in BDI.
- Patients who agree to sign informed consent sheet.
- Patients without a psychotherapeutic treatment during the 8 weeks prior to baseline.
- Patients with any pharmacological antidepressant treatment in continuation phase or maintenance (Eg. SSRIs, benzodiazepines) with good adherence.
You may not qualify if:
- Patients with psychotic symptoms.
- Patients with suicidal risk.
- Patients with comorbid Axis I.
- Patients with comorbid Axis II as the primary diagnosis.
- Patients with any type of hearing chronic medical illness, neurological or (Eg. Hearing loss, tinnitus, etc.)
- Patients with addiction to any substance (except caffeine and nicotine).
- Patients with medical or psychological problems related to music (Eg. Amusia or musicogenic Epilepsy.
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional de Psiquiatria Ramon de la Fuente Muñiz
Mexico City, Mexico City, 14370, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Enrique O Flores Gutierrez, MD PhD
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
- PRINCIPAL INVESTIGATOR
Jorge Julio González Olvera, MD PHD
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
April 16, 2015
First Posted
October 5, 2016
Study Start
October 1, 2016
Primary Completion
December 1, 2016
Study Completion
June 1, 2017
Last Updated
October 5, 2016
Record last verified: 2016-10